Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marlena Books is a healthcare company that develops specialized reading materials and digital tools designed for individuals living with dementia and Alzheimer's disease. The company's products utilize evidence-based design features, such as specific font sizes, spacing, and simplified sentence structures, to support cognitive function and engagement. By providing age-appropriate and accessible content, Marlena Books aims to reduce agitation and improve the quality of life for patients and their caregivers. In 2020, the company was acquired by SmileMakers to further integrate its therapeutic resources into the senior living and long-term care markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marlena Books.